Any idea whether drug companies can get updates during trials or are they completely walled off? Brian mentioned being “blinded” to the study during a call. Do you know when they are allowed to see data/make a decision to add a cohort?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.